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Abstract
We describe a new atypical Shiga-toxin-producing Escherichia coli
(STEC) responsible for a severe episode of haemolytic–uraemic
syndrome in an adult with a relapse associated with bacteraemia.
This STECs train of serotype O80:H2 harboured stx2c and stx2d
gene subtypes, the rare eae ξ variant and a ColV plasmid with a
conserved virulence plasmidic region involved in virulence of human
and avian extraintestinal pathogenic E. coli. This atypical hybrid
pathotype, which represents a new threat, is a further demonstra-
tion that STEC may be a recipient for extraintestinal virulence
factors and raises again the question of antibiotic therapy during
STEC infection.
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Introduction
Among the intestinal pathogenic Escherichia coli, Shi-
ga-toxin-producing E. coli (STEC) are major food-borne
emerging pathogens that cause bloody diarrhoea, which may
be complicated by the potentially fatal haemolytic–uraemic
syndrome (HUS), an important cause of acute renal failure [1].
The main virulence factor of STEC is the phage-encoded
cytotoxin called Shiga-toxin that exists as two main types—
Stx1 and Stx2 [2]. In most cases, STEC also carry an
enterocyte effacement pathogenicity island that causes the
attaching and effacing lesions on infected epithelial cells. While
other intestinal virulence factors have been described in STEC,
extraintestinal manifestations are rare and virulence factors
characteristic of extraintestinal pathogenic E. coli (ExPEC) have
been rarely reported.
Case Report
In April 2013, a 39-year-old male was admitted to the intensive
care unit because of afebrile generalized tonic–clonic seizure
followed by coma without focal abnormalities. White-cell
count was 10 200/mL, haemoglobin was 10 g/dL and platelet
count was 25 200/mm3 with indirect evidence of haemolysis.
The electrolyte balance was normal. Cultures of cerebrospinal
ﬂuid, blood and urine were initially sterile. A computed
tomographic brain scan revealed bilateral ischaemic lesions in
posterior cerebral artery territory and diffuse cerebral
oedema. An electroencephalographic study showed attenua-
tion of background activity without spike-wave discharges.
Furthermore, the patient received intravenous amoxicillin-cla-
vulanate during the ﬁrst 5 days of hospitalization for suspected
aspiration pneumonia.
Oligoanuric acute renal failure with hypertension occurred
3 days after admission. The serum creatinine concentration
increased up to 365 lmol/L. Blood tests revealed persistent
thrombopenia and haemolytic anaemia (haemoglobin 6.3 g/dL)
with schistocytes (3.5%). At the same time, the patient
presented one episode of non-bloody diarrhoea. Stool cultures
yielded a Shiga-toxin-2-producing E. coli, which conﬁrmed the
diagnosis of HUS. The patient required continuous veino-ve-
inous haemoﬁltration (21 days) and received several erythro-
cyte, platelet and plasma transfusions.
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Three weeks after his admission, while blood parameters
were returning to normal, the patient again presented severe
anaemia (haemoglobin, 6.1 g/dL) with thrombopenia (48 000/
mm3) and schistocytes (1.7%). He remained afebrile but two
blood cultures yielded a Shiga-toxin 2-producing E. coli. A
urine culture obtained 2 days before was negative for this
pathogen, indicating that urine was unlikely to be the source
of bacteraemia. Intravenous antibiotic therapy with piperacil-
lin-tazobactam and amikacin was initiated and the patient
received one plasmapheresis. As the STEC strain was still
detected in stools, he was treated with oral azithromycin to
suppress carriage. Stools became negative 6 days after this
treatment.
Ten weeks after admission, the patient was alert and
oriented and ischaemic lesions had completely regressed on
the computed tomographic brain scan. Serum creatinine level
was 44 lmol/L, haemoglobin level was 7.3 g/dL and platelet
count was 178 000/mm3.
Laboratory Results
Three isolates of STEC, successively recovered from stools
and blood cultures, were found to harbour stx2c, stx2d, hlyA
and eae genes. The eae ξ variant was identiﬁed by a speciﬁc
PCR [3]. Enteroaggregative E. coli virulence factors aggr, pic
and astA were negative. All the isolates harboured the O80
antigen (E. coli antisera; Statens Serum Institut, Copenhagen,
Denmark) and were resistant to aminopenicillins, cotrimox-
azole, nalidixic acid and kanamycin.
As the STEC strain was also isolated from blood cultures,
major virulence factors of ExPEC were sought by PCR. A ﬁrst
screening indicated the presence of genes encoding salmoch-
elin (iroN) and aerobactin (iucC), whose combination suggested
the presence of a conserved virulence plasmidic region
characteristic of ColV plasmids described in ExPEC strains
[4,5]. The presence of ompTp, etsC, iss, hlyF, sitA and cvaA
together with iroN and iucC, which are considered to be a
signature of this region, were identiﬁed in the three isolates.
All isolates were assigned to the phylogenetic group A with
a PCR-based method and to the sequence type 301 constit-
utive of STc 165 using the multilocus sequence typing Achtman
scheme (mlst.ucc.i.e/mlst/dbs/Ecoli). Pulsed-ﬁeld gel electro-
phoresis of XbaI-restricted DNA showed that the three
isolates were genetically related (Fig. 1). Furthermore, oligo-
nucleotide microarray results with 392 probes (Clondiag,
Alere, France) were identical for the three strains (data not
shown). Pulsed-ﬁeld gel electrophoresis of S1 nucle-
ase-digested DNA showed the presence of four plasmids for
each strain; three of similar sizes in all isolates plus one of high
(a) (b) (c) (d)
FIG. 1. Pulsed-ﬁeld gel electrophoresis of XbaI-restricted DNA (a) and of S1 nuclease-digested DNA (c) with the corresponding hybridizations by
Southern blot (b and d, respectively) of the three Shiga-toxin-producing O80:H2 Escherichia coli isolates. MW, molecular weight: lane 1, ﬁrst strain
isolated from stool; lane 2, strain isolated from blood culture; and lane 3, second strain isolated from stool. White arrows indicate plasmids and black
arrows indicate plasmid bands hybridizing with etsC probe.
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molecular weight (ranging from 150 kbp to 300 kbp), which
hybridized with iroN and etsC probes on Southern blot (Fig. 1).
The main characteristics of the O80:H2 STEC strain are
presented in Table 1.
Discussion
Here, we report the isolation of a new hybrid pathotype of
STEC serotype O80:H2. A ﬁrst unusual feature of this case
report is bacteraemia because, to our knowledge, only six
cases have been previously described during HUS [6–11].
Besides rare cases of STEC infection with bacteraemia, several
cases of urinary tract infection have been reported since the
ﬁrst report in 1996 of O103:H2 STEC [12]. Among all these
reports, very few searches for ExPEC virulence factors were
performed.
The O157:H7 STEC, the most frequent clonal group
involved in HUS does not harbour extraintestinal virulence
traits. However, combined virulence pathotypes have been
previously described in other serotypes. In 2011, the O104:H4
STEC, causing an outbreak of HUS in Europe, combined
Shiga-toxin Stx2a production, enteroaggregative genes and
two loci encoding the ExPEC siderophores aerobactin and
yersiniabactin [13]. The high pathogenicity island encoding
yersiniabactin is known to be disseminated among intestinal
pathogenic E. coli including certain clonal subgroups of STEC
[14,15]. Aerobactin has been found in more than 75% of
enteroaggregative E. coli strains but also in several STEC [14].
In contrast, the iro locus encoding salmochelins is extremely
rare in intestinal E. coli [14].
This is the ﬁrst time that a conserved virulence plasmidic
region characteristic of ExPEC has been described in one
STEC strain. This region is a key genetic determinant in ExPEC
strains virulent in humans and poultry [4,5]. Plasmids contain-
ing conserved virulence plasmidic regions have been especially
described in neonatal meningitis strains and are associated
with high levels of bacteraemia which favour the blood–brain
barrier passage [5,16]. The siderophores encoded by con-
served virulence plasmidic region play a key role in this
pathophysiological step; however, several genes of as yet
unknown function are still under investigation [17,18]. Our
results blur the classical distinction between intestinal and
extraintestinal pathogenic E. coli. Surprisingly, although very
TABLE 1. Genetic background of the new hybrid pathotype Escherichia coli O80:H2
Gene Description Presence
Virulence genes of Shiga-toxin-producing E. coli
stx1/vtx1 Shiga-toxin 1 Negative
stx2c/vtx2c Shiga-toxin 2 variant Positive
stx2d/vtx2d Shiga-toxin 2 variant Positive
eae Intimin (adhesin) Positive
E-hlyA Enterohaemolysin A Positive
saa Shiga-toxin-producing E. coli autoagglutination adhesin Negative
efa1 Enterohaemorragic E. coli factor for adherence Positive
tir Translocated intimin receptor protein Positive
espP Extracellular serine protease Positive
Virulence genes of enteropathogenic E. coli
bfpA Major subunit of bundle-forming pili Negative
Virulence genes of enteroaggregative E. coli
aggA Subunit of aggregative adherence ﬁmbria AAF/1 Negative
aggR Master regulator for a package of enteroaggregative
E. coli plasmid (pAA) virulence genes,
including AAF/I adherence factor
Negative
pic Pic protein with mucinase activity involved in the intestinal colonization Negative
sepA SepA. Shigella extracellular protein Negative
sigA SigA protein, IgA protease-like homologue Negative
astA Enteroaggregative E. coli heat-stable enterotoxin Negative
Virulence genes of extraintestinal pathogenic E. coli
fuyA Yersiniabactin siderophore (receptor) Negative
iroN Salmochelin siderophore (receptor) Positive
iutA Aerobactin siderophore (receptor) Positive
sitA Iron uptake system SitABCD Positive
cvaA Colicin V Positive
iss Increased serum survival gene Positive
etsC Type I secretion system Positive
hlyF Α-haemolysin (pore-forming toxin) Positive
ompT Outer membrane protein (omptin) Positive
mchF ABC transporter MchF (bacteriocin) Positive
sfa/foc S ﬁmbriae Negative
papC, papGIII, papGII P ﬁmbriae Negative
cnf1 Cytotoxic necrotizing factor 1 Negative
ibeA Endothelial invasin Negative
hra Haemagglutinin Negative
eitB ABC iron transporter Negative
tsh Temperature-sensitive haemagglutinin Negative
sat Serine protease autotransporter toxin Negative
vat Vacuolating autotransporter toxin Negative
cdt Cytolethal distending toxin Negative
clbN/clbB Colibactin Negative
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close in terms of virulence gene content and chromosomal
backbone, the three isolates differed in their ColV plasmid size.
The reasons for such apparent plasticity of the extraintestinal
virulence-associated plasmid between faecal and blood isolates
remain to be determined.
The serotype of our strain appears also to be atypical, as
O80:H2 STEC strains have rarely been described [2,3]. The
European Food Safety Authority reported in their Scientiﬁc
Opinion published in 2013 that O80 is an HUS-associated
serotype. However, among 777 HUS cases in Europe between
2007 and 2010, only two were related to O80 STEC strains
[19]. The subtype of stx2 genes in HUS-associated O80 strains
has not been previously described. Stx2d has been reported to
be one of the more potent toxins, similar to Stx2a [20], and
may in part explain the severe presentation of our case. The
potential role of the Stx2d and Stx2c combination in severe
presentations remains to be studied. Interestingly, our strain
harboured an infrequent intimin type that was described for
the ﬁrst time in two O80 STEC strains isolated from cattle [3].
Moreover, examining the EcMLST database, only two E. coli
strains of serotypes O80 and O4, respectively, belong to the
sequence type 301.
Finally, our case raises again the unsolved question of
antibiotic therapy during STEC infections. Here, we demon-
strated that a plasmid characteristic of ExPEC could be
transferred into an intestinal pathogenic E. coli genetic
background. This plasmid probably contributes to the
virulence, especially to establish bacteraemia. It is no longer
recommended to treat STEC infections with antibiotics
because such treatment has been associated with a higher
rate of subsequent HUS [2,21]. However, this novel hybrid
pathotype may represent a new threat and the risk of
bacteraemia may lead to a dramatic outcome in the context
of HUS. Among antibiotics, it has been shown that azithro-
mycin, in contrast to other antibiotics, is able to signiﬁcantly
reduce Shiga-toxin production in vitro [22] and to lower the
frequency of long-term carriage [23]. In our case, earlier
azithromycin treatment may have prevented the HUS
relapse.
The genetic plasticity of E. coli allows multiple gene com-
binations that result in phenotypic diversiﬁcation and the
emergence of new hypervirulent pathogens such as E. coliO80:
H2. This strain may represent a threat in terms of public health
requiring a redeﬁnition of the place of antibiotic treatment
during STEC infection.
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